President-elect Donald Trump’s key appointments for roles in the Department of Justice, Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA) have sparked significant concern among cannabis advocates. Pam Bondi, Dave Weldon, and Dr. Marty Makary—Trump’s picks for Attorney General, CDC Director, and FDA Commissioner, respectively—have all expressed strong opposition to marijuana reform. Throw that in with Trump’s VP, JD Vance, saying that all marijuana is laced with Fentanyl now, and you get the point.
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…
Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…
This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…
The cannabis industry does not need another study, another tax revenue report, or another state-level…
A liquor-retail trade group argued that the state’s cannabis oversight is lax and should look…